Ectopic ACTH-syndrome due to a thymic carcinoid tumor

Acta Clin Belg. 2002 Jan-Feb;57(1):23-5. doi: 10.1179/acb.2002.006.

Abstract

Investigating a recently developed Cushing Syndrome, we diagnosed in a 47-year-old woman an ectopic ACTH syndrome due to a metastatic carcinoid tumor, most likely a thymic carcinoid tumor. Combined therapy with sandostatin and nizoral and later on with sandostatin, metopirone and orimeten, was not able to suppress the hypercortisolism. A few weeks after surgical adrenalectomy, clinical deterioration ensued, culminating in the patient's death 7 months after diagnosis.

Publication types

  • Case Reports

MeSH terms

  • ACTH Syndrome, Ectopic / drug therapy
  • ACTH Syndrome, Ectopic / etiology*
  • Aminoglutethimide / therapeutic use
  • Antifungal Agents / therapeutic use
  • Antimetabolites / therapeutic use
  • Carcinoid Tumor / drug therapy
  • Carcinoid Tumor / metabolism*
  • Enzyme Inhibitors / therapeutic use
  • Fatal Outcome
  • Female
  • Hormones / therapeutic use
  • Humans
  • Ketoconazole / therapeutic use
  • Metyrapone / therapeutic use
  • Middle Aged
  • Octreotide / therapeutic use
  • Thymus Neoplasms / drug therapy
  • Thymus Neoplasms / metabolism*

Substances

  • Antifungal Agents
  • Antimetabolites
  • Enzyme Inhibitors
  • Hormones
  • Aminoglutethimide
  • Ketoconazole
  • Octreotide
  • Metyrapone